Read More Healthcare Industry News Suraksha Diagnostic Q1 FY26 results: How revenue growth, genomics expansion, and acquisitions are shaping investor outlook Suraksha Diagnostic Q1 FY26 revenue up 18.83%, PAT up 19.67%. See how genomics, acquisitions, and expansion are shaping its growth outlook. byPallavi MadhirajuAugust 9, 2025